Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Needham & Company Raises Price Target on Cardiovascular Systems (CSII) to $27 Following 4Q Beat
August 4, 2016 8:14 AM EDTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $27.00 (from $23.00), following the company's 4Q earnings report. Revenue was $48.5M vs. consensus of $46.0M and GAAP EPS was ($0.15) vs. consensus of ($0.20).
Analyst Mike Matson... More
BofA/Merrill Lynch Upgrades Cardiovascular Systems (CSII) to Neutral
August 4, 2016 6:51 AM EDTBofA/Merrill Lynch upgraded Cardiovascular Systems (NASDAQ: CSII) from Underperform to Neutral.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $19.74 yesterday.
... MoreCardiovascular Systems (CSII) Tops Q4 EPS by 5c; Offers Q1 Outlook
August 3, 2016 4:41 PM EDTCardiovascular Systems (NASDAQ: CSII) reported Q4 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $48.5 million versus the consensus estimate of $46.01 million.
GUIDANCE:
Cardiovascular Systems sees Q1 2017 EPS of ($0.21)-($0.18). Cardiovascular Systems sees Q1 2017... More
